Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01765400 · ClinicalTrials.gov registry record · Phase 4
Platelet Inhibition in Patients With Systolic Heart Failure
A Phase 4 study of Systolic Heart Failure, sponsored by University of Nebraska.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT01765400 is a Phase 4 study of Systolic Heart Failure that has completed, run by University of Nebraska. The registered enrollment target is 30 participants, below the 126-participant average among 3 other Systolic Heart Failure trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01765400, a Phase 4 study of Systolic Heart Failure, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators aim to determine if patients with systolic heart failure treated with prasugrel achieve greater platelet inhibition compared to those treated with clopidogrel.
Conditions Studied
Interventions
- DRUG Prasugrel 10 mg daily x 2 weeks
- DRUG Clopidogrel 75 mg daily x 2 weeks
Study Locations (1)
Nebraska
- University of Nebaska Medical Center - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-05-15 |
| Est. Completion | 2015-12-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01765400
The ClinicalTrials.gov registry entry for NCT01765400 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 126-participant average among 3 other Systolic Heart Failure trials with a reported enrollment target (76% lower). The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Systolic Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which Prasugrel 10 mg daily x 2 weeks is the first listed.
NCT01765400 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.
Frequently Asked Questions
What is clinical trial NCT01765400 about?
NCT01765400 is a clinical study titled "Platelet Inhibition in Patients With Systolic Heart Failure". The investigators aim to determine if patients with systolic heart failure treated with prasugrel achieve greater platelet inhibition compared to those treated with clopidogrel.
What is the current status of trial NCT01765400?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2013-05-15. Estimated completion is 2015-12-28.
What conditions does trial NCT01765400 study?
This clinical trial studies the following conditions: Systolic Heart Failure.
What interventions are being tested in trial NCT01765400?
The interventions under investigation include: Prasugrel 10 mg daily x 2 weeks (DRUG), Clopidogrel 75 mg daily x 2 weeks (DRUG).
Who is sponsoring clinical trial NCT01765400?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01765400 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Systolic Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neuromodulation of Inflammation and Endothelial Function
RECRUITING · NA
-
A Trial Comparing High-Flow Nasal Cannula Versus Noninvasive Ventilation on Reintubation and Post-Extubation Respiratory Failure in High-Risk Patients With Systolic Heart Failure
RECRUITING · NA
-
Medical Arm of the Interagency Registry for Mechanically Assisted Circulatory Support
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.